Device Trial Radar · NCT06915363
BioPoly® Partial Resurfacing Knee Implant IDE
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
152
Planned (sponsor's estimate)
Start
Mar 17, 2025
Primary completion
Dec 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- BioPoly LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 8, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 30 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this randomized controlled clinical trial is to demonstrate the safety and effectiveness of the BioPoly® Partial Resurfacing Knee Implant for the treatment of cartilage defects of the distal femur in adult patients with knee pain and symptoms who are candidates for surgical intervention of the knee compared to outcomes for the control group. The primary effectiveness endpoint is Month 24 composite clinical success (CCS) defined by: * no secondary surgical intervention (SSI) and * an improvement from baseline in the Knee injury and Osteoarthritis Outcome Score (KOOS) total score (scaled 0 to 100) of at least 10 points. Researchers will compare the CCS for the investigational device group to a control group receiving the standard of care, either microfracture or debridement). Subjects randomized to the investigational group will receive the BioPoly Knee device and those randomized to the control group will receive the current standard of care, either microfracture or debridement.
Conditions
- Knee Pain Chronic
- Knee Osteoarthritis
- Cartilage Damage
- Cartilage Defects of the Knee
- Cartilage or Osteochondral Defects in the Knee
- Cartilage Lesion
Interventions
BioPolyDevice
partial resurfacing knee replacement
surgical standard of care (SSOC)Procedure
either microfracture or debridement
Primary outcomes
What the sponsor says the trial is designed to measure.
- Improvement in the Knee injury and Osteoarthritis Outcome Score (KOOS) to Assess Composite Clinical Success (CCS) effectivenessTime frame: 24 months
- Composite Clinical Success (CCS) Safety as Measured by No Secondary Surgical IntenventionTime frame: 24 months
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Stanford Medicine Dept of Orthopaedic Surgery
Redwood City, California · Recruiting
Dupont Hospital
Fort Wayne, Indiana · Recruiting
OrthoIndy
Indianapolis, Indiana · Withdrawn
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.